GSK Analyst Price Targets - Benzinga

GSK PLC

GSKNYSE

Trade with Public

Trade with Public

$50.75

-0.46-0.9%

Dern. MÀJ: Oct 23, 6:30 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

GSK Analyst Price Targets

Wall Street analyst price targets and consensus rating for GSK (GSK).

Price Target Range — 3 Quarters

Analyst Consensus — 6 Analysts

1Buy

4Hold

1Sell

Consensus RatingEqual-Weight# Analysts6Avg. Consensus PT$46Upside to Avg. PT-10.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 24, 2026	Citigroup	Graham Parry	Reinstates	Neutral	—
Jan 6, 2026	Barclays	James Gordon	Downgrade	Equal-Weight→Underweight	—
Oct 27, 2025	Jefferies	Michael Leuchten	Assumes	Hold→Buy	—
Nov 12, 2024	Jefferies	Peter Welford	Downgrade	Buy→Hold	—
Oct 31, 2024	Guggenheim	Seamus Fernandez	Downgrade	Buy→Neutral	—
Jul 8, 2024	UBS	Jo Walton	Downgrade	Buy→Neutral	—
Jul 2, 2024	Jefferies	Peter Welford	PT Raise	Buy	$53→$53
May 30, 2024	Goldman Sachs	Rajan Sharma	Initiate	Neutral	$47
Mar 4, 2024	Guggenheim	Seamus Fernandez	Upgrade	Neutral→Buy	—
Jan 23, 2024	Morgan Stanley	Mark Purcell	Initiate	Equal-Weight	$44
Jan 3, 2024	Jefferies	Peter Welford	Upgrade	Hold→Buy	$39→$48

Analyst Ratings News

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Analysts review high-yield healthcare stocks CVS, Medtronic and GSK, offering dividend yields of 3.02%-3.86% and varied ratings.

Avi Kapoor

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.74%) and GSK (3.65%).

Avi Kapoor

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst ratings for high-yield stocks in health care.

Avi Kapoor

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent markets. Check out analyst ratings and news for high-yielding stocks on Benzinga's Analyst Stock Ratings page.

Avi Kapoor

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ratings page provides latest analyst takes on top stocks, sorted by accuracy. Ratings for three high-yielding health care stocks: VTRS, MDT, GSK. VTRS to report Q2 results on Aug.6, MDT recalls certain catheter system, GSK reports positive trial results. Benzinga Pro's newsfeed provides real-time alerts.

Avi Kapoor

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst ratings for high-yielding stocks, including accuracy rates.

Avi Kapoor